<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02123628</url>
  </required_header>
  <id_info>
    <org_study_id>2006-00625-14</org_study_id>
    <nct_id>NCT02123628</nct_id>
  </id_info>
  <brief_title>Antibiotic Treatment Duration for Non-Surgically-Treated Diabetic Foot Osteomyelitis</brief_title>
  <acronym>C H R O N O S</acronym>
  <official_title>Six- Versus Twelve-Week Therapy for Non-Surgically-Treated Diabetic Foot Osteomyelitis: A Multicenter Open-Label Controlled Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tourcoing Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tourcoing Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to compare the efficacy and tolerance of 6- versus 12-week
      antibiotic therapy in patients with diabetic foot osteomyelitis treated medically.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this randomized multicenter clinical study is to compare the efficacy and
      tolerance of 6 versus 12-week antibiotic treatment in patients with diabetic foot
      osteomyelitis treated medically as no equivalent data are currenty available in the
      literature.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2007</start_date>
  <completion_date type="Actual">September 2012</completion_date>
  <primary_completion_date type="Actual">June 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary outcome measure was the proportion of patients of each group with remission of diabetic foot osteomyelitis at the end of follow-up.</measure>
    <time_frame>one year</time_frame>
    <description>Remission was defined as the absence of any sign of infection at the initial or a contiguous site, evaluated at least one year after the end of antibiotic treatment (ie at the end of follow-up), with neither a new infectious episode nor the need for orthopedic surgery of the foot at either of these sites during the treatment and follow-up period.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>tolerance to treatment in each group of patients</measure>
    <time_frame>6 or 12 weeks</time_frame>
    <description>number of episodes of adverse events attributable to the antibiotic treatment recorded in each group of patients.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>antibiotic therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients are treated with a 6 week-duration of antibiotic therapy :
Rifampin IP and PO twice daily, 10mg/kg /12H
Levofloxacin IV and PO 500-750mg once daily
Doxycycline PO 200mg once daily
Trimethoprim- sulfamethoxazole IV and PO 800/160mg thrice daily
Fusidic acid PO 500mg twice daily
Linezolid IV and PO 600mg twice daily
Ciprofloxacin IV and PO 750to 1000mg/12h
Cefotaxime IV 100mg/kg in three IV infusions daily
Ceftriaxone IV,intramuscularly or subcutaneously 2g once daily
Cefepime IV ou intra-muscularly 2g /8-12h</description>
  </arm_group>
  <arm_group>
    <arm_group_label>12 week-duration of antibiotic therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients are treated with a 12 week-duration of antibiotic therapy :
Rifampin IP and PO twice daily, 10mg/kg /12H
Levofloxacin IV and PO 500-750mg once daily
Doxycycline PO 200mg once daily
Trimethoprim- sulfamethoxazole IV and PO 800/160mg thrice daily
Fusidic acid PO 500mg twice daily
Linezolid IV and PO 600mg twice daily
Ciprofloxacin IV and PO 750to 1000mg/12h
Cefotaxime IV 100mg/kg in three IV infusions daily
Ceftriaxone IV,intramuscularly or subcutaneously 2g once daily
Cefepime IV ou intra-muscularly 2g /8-12h</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>duration of the antibiotic therapy</intervention_name>
    <arm_group_label>antibiotic therapy</arm_group_label>
    <arm_group_label>12 week-duration of antibiotic therapy</arm_group_label>
    <other_name>- Rifampin</other_name>
    <other_name>- Levofloxacin</other_name>
    <other_name>- Doxycycline</other_name>
    <other_name>- Trimethoprim- sulfamethoxazole</other_name>
    <other_name>- Fusidic acid</other_name>
    <other_name>- Linezolid</other_name>
    <other_name>- Ciprofloxacin</other_name>
    <other_name>- Cefotaxime</other_name>
    <other_name>- Ceftriaxone</other_name>
    <other_name>- Cefepime</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diabetic patients treated non-surgically (i.e. without amputation or resection of the
             infected bone) for an osteomyelitis of the foot complicating a neuropathic foot
             without ischemia of the foot defined as the absence of any pedal pulse. Patients aged
             of 18 years or more were included if they had type 2 diabetes and osteomyelitis of the
             foot (i.e.below the ankle).

        Exclusion Criteria:

          -  Patients with gangrene or who require bone resection or amputation when osteomyelitis
             of the foot was diagnosed
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric M Senneville, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Dron Hospital of Tourcoing France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alina Tone, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dron Hospital Tourcoing France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dron Hospital</name>
      <address>
        <city>Tourcoing</city>
        <state>Nord</state>
        <zip>59200</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 15, 2014</study_first_submitted>
  <study_first_submitted_qc>April 22, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 25, 2014</study_first_posted>
  <last_update_submitted>April 22, 2014</last_update_submitted>
  <last_update_submitted_qc>April 22, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 25, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>diabetic foot osteomyelitis, antibiotic treatment duration</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetic Foot</mesh_term>
    <mesh_term>Osteomyelitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Doxycycline</mesh_term>
    <mesh_term>Ciprofloxacin</mesh_term>
    <mesh_term>Levofloxacin</mesh_term>
    <mesh_term>Ofloxacin</mesh_term>
    <mesh_term>Rifampin</mesh_term>
    <mesh_term>Linezolid</mesh_term>
    <mesh_term>Ceftriaxone</mesh_term>
    <mesh_term>Cefepime</mesh_term>
    <mesh_term>Trimethoprim, Sulfamethoxazole Drug Combination</mesh_term>
    <mesh_term>Cefotaxime</mesh_term>
    <mesh_term>Cefoxitin</mesh_term>
    <mesh_term>Fusidic Acid</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
    <mesh_term>Trimethoprim</mesh_term>
    <mesh_term>Sulfamethoxazole</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

